Eucrates Biomedical Acquisition Corp.
EUCR · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $142 | $521 | $432 | $1,325 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$128 | $122 | $83 | -$9 |
| Other Non-Cash | -$405 | -$688 | -$569 | -$1,456 |
| Operating Cash Flow | -$391 | -$45 | -$54 | -$140 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$250 | $0 | $0 | $250 |
| Financing Cash Flow | -$92,841 | $0 | $0 | $250 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$41 | -$45 | -$54 | $110 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $60 | $105 | $159 | $49 |
| End Cash | $19 | $60 | $105 | $159 |
| Free Cash Flow | -$391 | -$45 | -$54 | -$140 |